0331 Reg qts
BioCentury & Getty Images

Regulation

March 31 Quick Takes: Basket of EU approvals includes MS, SMA drugs; plus Amarin, AbbVie, Cara-Vifor 

Mar 31, 2021 | 11:04 PM GMT

The European Commission approved Kesimpta ofatumumab from Novartis AG (NYSE:NVS; SIX:NOVN) to treat relapsing forms of multiple sclerosis.

Read the full 439 word article

How to gain access

Continue reading with a
two-week free trial.